Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2023, Forbes has recognized Grifols as one of the “Best Employers for Women.” To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.
View Top Employees from GrifolsWebsite | https://linktr.ee/Grifols |
Ticker | GRFS |
Revenue | $5.2 billion |
Employees | 10,764 (8,395 on RocketReach) |
Founded | 1909 |
Address | 152 Avinguda De La Generalitat, Sant Cugat del Vallès, Catalonia 08174, ES |
Phone | +34 935 71 22 00 |
Fax | +34 935 71 02 67 |
Technologies |
JavaScript,
HTML,
Twitter
+251 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Medical Supplies, Plasmapheresis, Healthcare, Surgical Devices, Plasma derived therapies, Diagnostics |
Keywords | Biopharmaceuticals, Plasma, Therapeutic Activities, Healthcare Solution, Transfusion Medicine, Infectious Disease Treatments |
Competitors | Amgen, Baxter International Inc., CSL, Octapharma Canada Inc., Regeneron |
SIC | SIC Code 382 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 6215 Companies, NAICS Code 33 Companies, NAICS Code 62 Companies, NAICS Code 621 Companies, NAICS Code 62151 Companies, NAICS Code 339 Companies |
Looking for a particular Grifols employee's phone or email?
The Grifols annual revenue was $5.2 billion in 2024.
8,395 people are employed at Grifols.
Grifols is based in Sant Cugat del Vallès, Catalonia.
The NAICS codes for Grifols are [6215, 33, 62, 621, 62151, 339].
The SIC codes for Grifols are [382, 38].